Sundar PichaiSundar Pichai earned $164M in 2023
L

Carole Ben-Maimon, M.D.

CEO of Larimar Therapeutics

Education

B.S. from the University of Pennsylvania; M.D. from Jefferson Medical College.

Born

January 1, 1961 - 64 years ago

Economy Sector

Healthcare

Current Tenure

4 years 8 months (May 2020 - Present)

Previous Experience

President and CEO of Chondrial Therapeutics, Inc.; President of Global Pharmaceuticals at Impax Laboratories; various roles in Barr Pharmaceuticals and Teva Pharmaceutical Industries.

Carole Ben-Maimon, M.D. is the President and CEO of Larimar Therapeutics, a biopharmaceutical company focused on developing treatments for rare diseases. With a solid educational background, she earned her B.S. from the University of Pennsylvania and her M.D. from Jefferson...

Year

2023

Total Compensation

$865.00K

Salary

$560.00K

Board Justification

Our executive compensation program is designed to attract, motivate and retain our named executive officers who are critical to our success, aligning with our pay-for-performance philosophy.

Bonus

$288.40K

Board Justification

Represents bonus paid in February 2024 based upon 2023 corporate performance, as approved by our Compensation Committee or Board, as applicable.

Other

$16.60K

Board Justification

Includes the Company’s contribution to a 401(k) plan and the value of group term life benefits provided by the Company.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was reported as vested in 2023.

Performance Metrics

The 2023 annual bonuses for Dr. Ben-Maimon were targeted at 50% of her base salary, with an overall achievement level of 103%.